A detailed history of Cibc World Markets Corp transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 15,040 shares of MRVI stock, worth $47,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,040
Previous 24,508 38.63%
Holding current value
$47,225
Previous $54,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$1.72 - $2.47 $16,284 - $23,385
-9,468 Reduced 38.63%
15,040 $36,000
Q1 2025

May 13, 2025

BUY
$2.21 - $6.13 $31,320 - $86,874
14,172 Added 137.11%
24,508 $54,000
Q4 2024

Feb 10, 2025

BUY
$4.42 - $8.5 $45,685 - $87,856
10,336 New
10,336 $56,000
Q1 2024

May 13, 2024

BUY
$5.11 - $8.76 $233,710 - $400,647
45,736 New
45,736 $396,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $413M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.